Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Exercise for osteoarthritis of the knee
2015
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
2016
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register
2008
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
2009
A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions: PRISMS – Practical systematic RevIew of Self-Management Support for long-term conditions
2014 Standout
Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
2011
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
2012 Standout
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
2004
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Rheumatoid arthritis
2018 Standout
Psoriasis
2009 Standout
Management of RA medications in pregnant patients
2009
Low and stable prevalence of rheumatoid arthritis in northern France
2009
Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial
2009
Rheumatoid arthritis
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Differentiating the efficacy of the tumor necrosis factor inhibitors
2005
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes
2012 StandoutNobel
Cochrane reviews of educational and self-management interventions to guide nursing practice: A review
2008 Standout
Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis
2007
OARSI guidelines for the non-surgical management of knee osteoarthritis
2014 Standout
Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata
2008
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
2005
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial
2009
The Fear-Avoidance Model of Musculoskeletal Pain: Current State of Scientific Evidence
2006 Standout
Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature
2008
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Psoriasis
2021 Standout
Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding
2012
Patient and public involvement in chronic illness: beyond the expert patient
2009 Standout
Exercise for osteoarthritis of the knee
2008
Osteoarthritis
2015 Standout
Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
2009
Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions
2015
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
2008
Immunity, Inflammation, and Cancer
2010 Standout
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Effect of Etanercept Plus Lamivudine in a Patient With Rheumatoid Arthritis and Viral Hepatitis B
2008
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Effect of therapeutic exercise for hip osteoarthritis pain: Results of a meta‐analysis
2008
Delineation of Self-Care and Associated Concepts
2011 Standout
Does land-based exercise reduce pain and disability associated with hip osteoarthritis? A meta-analysis of randomized controlled trials
2010
Rheumatoid arthritis
2010 Standout
Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients
2009
Prevalence of anxiety and depression in osteoarthritis: use of the Hospital Anxiety and Depression Scale as a screening tool
2010
Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease
2010
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
2010
The Individual and Family Self-Management Theory: Background and perspectives on context, process, and outcomes
2009 Standout
Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action
2010
Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis
2013
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study
2007
Hidradenitis suppurativa
2020 Standout
The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literature
2008
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections
2007
Outcome of subacute low back pain: influence of patients' and rheumatologists' characteristics
2005
Systematic review of non-surgical therapies for osteoarthritis of the hand: an update
2009
Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
2007
Osteoarthritis
2019 Standout
Biologic therapy and pregnancy outcomes in women with rheumatic diseases
2009
Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease
2009
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Rheumatoid Arthritis
2008
Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review
2011
Histological evaluation of liver in two rheumatoid arthritis patients with chronic hepatitis B and C treated with TNF-alpha blockade: case reports
2008
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Hidradenitis Suppurativa Associated with Spondyloarthritis — Results from a Multicenter National Prospective Study
2014
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Self-management education programmes for osteoarthritis
2014 Standout
Measures of anxiety: State‐Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale‐Anxiety (HADS‐A)
2011 Standout
American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma
2002
Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults
2010
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
The effectiveness of self-management educational interventions for osteoarthritis of the knee
2009
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Rheumatoid Arthritis: A Female Challenge
2008
Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs
2008
Etanercept for the treatment of rheumatoid arthritis
2013
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Etanercept for the Treatment of Rheumatoid Arthritis
2018
Exercise for osteoarthritis of the hip
2014
The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
2006
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Tropical pyomyositis (myositis tropicans): current perspective
2004
Prosthetic Joint Infection
2014 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
Multiple Myeloma
2011 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs
2013
Industry sponsorship and research outcome
2017 Standout
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
2008
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Meta-Analysis: Chronic Disease Self-Management Programs for Older Adults
2005
A systematic review of the role of bisphosphonates in metastatic disease
2004
Works of L Euller-Ziegler being referenced
Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM).
1994
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)- therapy
2006
Etanercept Compared to Intraarticular Corticosteroid Injection in Rheumatoid Arthritis: Double-blind, Randomized Pilot Study
2011
Injection of intra-articular sodium hyaluronidate (Sinovial®) into the carpometacarpal joint of the thumb (CMC1) in osteoarthritis. A prospective evaluation of efficacy
2007
Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study
2008
Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2×2 factorial design
2004
Safety of anti-TNF- therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis
2006
Prognostic factors in low tumour mass asymptomatic multiple myeloma: A report on 91 patients
1995
Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France.
2007
[Etanercept--infliximab switch in rheumatoid arthritis 14 out of 131 patients treated with anti TNFalpha].
2002
Pyomyositis: cervical localization.
1993
[Treatment of systemic scleroderma with factor XIII in 86 patients, with long-term follow-up].
1985
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)- therapy reply to correspondence: reply
2007
[Long-term treatment of systemic scleroderma with coagulation factor XIII. Developmental monitoring, especially of respiratory function].
1984
New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
2007